Defunct Company
Total Trials
16
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,291
NCT01559701
Long-term Safety of PF-00345439 (Oxycodone)
Phase: Phase 3
Role: Lead Sponsor
Start: Apr 30, 2006
Completion: Feb 29, 2008
NCT00399113
Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
Phase: Phase 1
Start: May 31, 2007
Completion: Not specified
NCT00734461
Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse
Phase: Phase 2
Start: Aug 31, 2007
Completion: Mar 31, 2009
NCT00734188
Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
Start: Jan 31, 2009
Completion: Jun 30, 2010
NCT01552863
A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers
Start: Mar 31, 2012
Completion: Sep 30, 2012
NCT01552850
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone
Start: Apr 30, 2012
Completion: Jun 30, 2012
NCT01717027
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
Start: Nov 30, 2012
Completion: Jan 31, 2013
NCT01924676
Food Effect And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
Start: Aug 31, 2013
Completion: Oct 31, 2013
NCT01986283
Abuse Potential Study of PF-00345439
Start: Nov 30, 2013
Completion: Aug 31, 2014
NCT02059915
Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions
Start: Apr 30, 2014
Completion: Jul 31, 2014
NCT02089295
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions
Completion: Jun 30, 2014
NCT02117583
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
NCT02165930
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
Start: Jul 31, 2014
NCT03475862
Nasal Human Abuse Potential of PTI-821
Start: May 15, 2017
Completion: Dec 15, 2017
NCT03784300
A Safety Study of PTI-125 in Healthy Volunteers
Start: Aug 18, 2017
Completion: Mar 27, 2018
NCT03748706
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
Start: Mar 7, 2019
Completion: May 8, 2019